Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome
Open accessAbstract
Sensory processing deficits are common in autism spectrum disorders, but the underlying mechanisms are unclear. Fragile X Syndrome (FXS) is a leading genetic cause of intellectual disability and autism. Electrophysiological responses in humans with FXS show reduced habituation with sound repetition and this deficit may underlie auditory hypersensitivity in FXS. Our previous study in Fmr1 knockout (KO) mice revealed an unusually long state of increased sound-driven excitability in auditory cortical neurons suggesting that cortical responses to repeated sounds may exhibit abnormal habituation as in humans with FXS. Here, we tested this prediction by comparing cortical event related potentials (ERP) recorded from wildtype (WT) and Fmr1 KO mice. We report a repetition-rate dependent reduction in habituation of N1 amplitude in Fmr1 KO mice and show that matrix metalloproteinase −9 (MMP-9), one of the known FMRP targets, contributes to the reduced ERP habituation. Our studies demonstrate a significant up-regulation of MMP-9 levels in the auditory cortex of adult Fmr1 KO mice, whereas a genetic deletion of Mmp-9 reverses ERP habituation deficits in Fmr1 KO mice. Although the N1 amplitude of Mmp-9/Fmr1 DKO recordings was larger than WT and KO recordings, the habituation of ERPs in Mmp-9/Fmr1 DKO mice is similar to WT mice implicating MMP-9 as a potential target for reversing sensory processing deficits in FXS. Together these data establish ERP habituation as a translation relevant, physiological pre-clinical marker of auditory processing deficits in FXS and suggest that abnormal MMP-9 regulation is a mechanism underlying auditory hypersensitivity in FXS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 47 cited sources checked · 0 supported · 0 flagged
- Findingown data
In the auditory cortex of P40 Fmr1 knockout mice, MMP-2 protein levels do not differ from wildtype mice.
“In contrast, MMP-2 levels are not different between Fmr1 KO (M = 35.97) and WT (M = 35.16) mice (t(8) = 0.13, p = 0.8983).”
Quote in the paperNot a substantial claim - Findingown data
Mmp-9/Fmr1 double knockout mice have shorter N1 latencies than wildtype mice at 0.25 and 0.5 Hz.
“The only rates to reach significance were the lowest rates of 0.25Hz (t(12) = 2.577, p = 0.024, r = 0.60), and 0.5Hz (t(12) = 3.558, p = 0.004, r = 0.72), with Mmp-9/Fmr1 DKO having consistently shorter N1 latencies (Figure 5A, B).”
Quote in the paperSubstantial claim - Findingown data
In the auditory cortex of P40 Fmr1 knockout mice, MMP-9 protein levels are higher than in wildtype mice.
“Gel zymography revealed a significant increase in levels of MMP-9 in Fmr1 KO (mean intensity, M = 45.47), compared to WT (M = 22.39) mice (Figure 1).”
Quote in the paperSubstantial claim - Findingown data
For repetition rates from 0.5 to 4 Hz, Fmr1 knockout mice show consistent N1 amplitude habituation deficits compared with wildtype and Mmp-9/Fmr1 double knockout mice.
“This indicates that for repetition rates between 0.5 and 4 Hz, Fmr1 KO mice show consistent N1 amplitude habituation deficits compared with WT and Mmp-9/Fmr1 DKO mice.”
- Also stated in: § Abstract · plain
“We report a repetition-rate dependent reduction in habituation of N1 amplitude in Fmr1 KO mice”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
In all genotypes, N1 latency variability across the train increases as repetition rate increases.
“In all genotypes, as repetition rate increased, variability in N1 latencies across the train also increased.”
Quote in the paperNot a substantial claim
- Findingown data
The average N1 amplitude over 20 sound repetitions does not differ between wildtype and Fmr1 knockout mice.
“Post-hoc Bonferroni tests show that WT and Fmr1 KO are not different in N1 amplitudes (p = 0.723)”
Quote in the paperNot a substantial claim - Findingown data
Mmp-9 knockout mice do not differ from wildtype mice in the steady-state habituation parameter y0 at any repetition rate.
“Also, Mmp-9 KO mice were compared with WT at each rate for y0, with no difference seen at any repetition rate (all p > 0.05).”
Quote in the paperNot a substantial claim - Findingown data
At 3 and 4 Hz repetition rates, Mmp-9/Fmr1 double knockout mice have higher N1 amplitudes than wildtype mice.
“Pairwise comparisons of WT and Mmp-9/Fmr1 DKO mice show higher amplitudes in Mmp-9/Fmr1 DKO mice for the 3 and 4 Hz rates (Figure 2D).”
Quote in the paperSubstantial claim - Findingown data
Mmp-9 knockout mice do not differ from wildtype mice in N1 latency Fano factor at any repetition rate.
“Mmp-9 KO showed no difference in Fano factor when compared to WT at any rate using independent samples t-tests, (all p > 0.05, data not shown).”
Quote in the paperSubstantial claim - Findingown data
Mmp-9 knockout mice do not differ from wildtype mice in N1 latency at any tested repetition rate.
“Mmp-9 KO also showed no difference in latency at any rate tested when compared to WT animals (all p > 0.05, data not shown).”
Quote in the paperNot a substantial claim - Findingown data
Across the tested mouse groups, the average N1 amplitude over 20 sound repetitions varies with the repetition rate.
“These data indicate that the average N1 amplitude across 20 repetitions was dependent on the repetition rate in all groups of mice tested.”
Quote in the paperNot a substantial claim - Findingown data
Mmp-9/Fmr1 double knockout mice have larger average N1 amplitudes than both wildtype and Fmr1 knockout mice.
“Although the N1 amplitude of Mmp-9/Fmr1 DKO recordings was larger than WT and KO recordings, the habituation of ERPs in Mmp-9/Fmr1 DKO mice is similar to WT mice”
Quote in the paperNot a substantial claim - Findingown data
Removing MMP-9 in Fmr1 KO mice reverses the ERP habituation deficit.
“However, removal of MMP-9 in the Fmr1 KO mice reverses the ERP habituation deficit seen in the Fmr1 KO mice.”
Quote in the paperSubstantial claim - Findingnone given
MMP-9 levels were abnormally high in Fmr1 KO auditory cortex.
“MMP-9 levels were abnormally high in the auditory cortex of Fmr1 KO mice”
Quote in the paperSubstantial claim - Findingown data
No genotype differences in N1 latency variability appeared at any other individual repetition rate (p>0.05).
“No differences were found between genotypes at any other individual rate as well (p > 0.05)”
Quote in the paperSubstantial claim - Findingown data
Mmp-9 KO and WT mice had similar ERPs in all tested respects except for a small N1 amplitude difference at 0.25 Hz.
“Mmp-9 KO and WT mice ERPs were similar in all regards tested except for the small N1 amplitude difference at 0.25 Hz rate.”
Quote in the paperNot a substantial claim - Findingown data
Differences in the Mmp-9/Fmr1 DKO genotype appear only when all repetition rates are combined.
“so differences in Mmp-9/Fmr1 DKO genotype only emerge when all rates are pooled together.”
Quote in the paperNot a substantial claim - Findingown data
Fmr1 KO mice showed impaired reduction of steady-state N1 amplitude across the stimulus train.
“We observed an impaired reduction in the steady state N1 amplitude across the stimulus train in Fmr1 KO mice”
Quote in the paperSubstantial claim - Findingown data
N1 habituation in Mmp-9/Fmr1 DKO mice resembled that in WT mice.
“N1 habituation in Mmp-9/Fmr1 DKO mice was similar to WT mice”
Quote in the paperSubstantial claim - Findingown data
The deviant sound paradigm revealed no genotype differences except abnormal habituation at the 5 Hz rate in Fmr1 KO mice.
“The deviant sound paradigm in this study, however, did not reveal differences between genotypes except for abnormal habituation for the 5 Hz rate in Fmr1 KO mice.”
Quote in the paperNot a substantial claim- Rests on an assumption: The fixed-position deviant sound paradigm is adequate to detect stimulus contrast detection deficits in Fmr1 KO mice.
- Findingown data
MMP-9 levels were higher in adult auditory cortex of Fmr1 KO mice than in WT mice.
“MMP-9 levels were higher in the adult auditory cortex of Fmr1 KO mice compared to WT mice”
Quote in the paperSubstantial claim - Findingown data
Unlike human FXS data, N1 amplitude was not higher in Fmr1 KO than WT mice.
“However, unlike data from humans with FXS, the N1 amplitude was not higher in the Fmr1 KO compared to WT mice.”
Quote in the paperNot a substantial claim - Findingown data
Steady-state N1 amplitude habituation was significantly reduced in Fmr1 KO mice compared with WT in a repetition-rate-dependent manner.
“There was a significant repetition rate-dependent reduction in steady state habituation of N1 amplitudes in Fmr1 KO mice compared to WT mice”
Quote in the paperSubstantial claim - Findingown data
ERP habituation deficits were reversed in Mmp-9/Fmr1 DKO mice.
“the ERP habituation deficits were reversed in Mmp-9/Fmr1 DKO mice”
Quote in the paperSubstantial claim - Findingown data
Deviant stimulus responses showed no genotype differences detectable in N1 amplitude.
“The deviant stimulus response did not show differences across genotypes that were detectable with N1 amplitudes.”
Quote in the paperNot a substantial claim - Findingown data
In the 5 Hz deviant paradigm, normalized N1 amplitude showed a main effect of position (F(8,162)=14.289, p<0.000001), indicating habituation across the train in all genotypes.
“Two-way ANOVA on normalized N1 amplitude of genotype and position in the train revealed a main effect of position (F(8,162) = 14.289, p < 0.000001), indicating that habituation across the train occurs for all genotypes.”
Quote in the paperNot a substantial claim - Findingown data
Despite elevated N1 amplitudes, Mmp-9/Fmr1 DKO mouse ERPs habituated at all rates similarly to WT.
“However, even with elevated N1 amplitudes, Mmp-9/Fmr1 DKO mouse ERPs show habituation at all rates in a manner similar to WT mice.”
Quote in the paperSubstantial claim - Interpretationown data
MMP-9 is a potential target for reversing sensory processing deficits in Fragile X Syndrome.
“implicating MMP-9 as a potential target for reversing sensory processing deficits in FXS.”
Quote in the paperSubstantial claim - Interpretationown data
MMP-9 contributes to the reduced auditory event-related potential habituation in Fmr1 knockout mice.
“We report a repetition-rate dependent reduction in habituation of N1 amplitude in Fmr1 KO mice and show that matrix metalloproteinase −9 (MMP-9), one of the known FMRP targets, contributes to the reduced ERP habituation.”
Quote in the paperSubstantial claim - Premisecitation
A previous electrophysiology study found abnormally sustained sound responses in auditory cortical neurons of Fmr1 knockout mice.
“A previous electrophysiology study revealed an abnormally sustained response to sounds in auditory cortical neurons in Fmr1 KO mice (Rotschafer and Razak, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rotschafer and Razak, 2013
Not checked in the free run.
- Premisecitation
MMP-9 is elevated in the cortex and hippocampus of both humans with Fragile X Syndrome and Fmr1 knockout mice.
“MMP-9 is elevated in the cortex and hippocampus of both humans with FXS and Fmr1 KO mice (Sidhu et al., 2014; Gkogkas et al., 2014).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
Increased MMP-9 levels suggest enhanced endogenous MMP-9 activity in the auditory cortex of Fmr1 knockout mice.
“Increased MMP-9 levels suggest enhanced endogenous activity of MMP-9 in the auditory cortex of Fmr1 KO mice providing a justification for examining the effects of Mmp-9 deletion on auditory electrophysiological responses in Fmr1 KO mice.”
Quote in the paperSubstantial claim - Interpretationnone given
The impaired auditory event-related potential habituation in Fmr1 knockout mice resembles the habituation deficits observed in humans with Fragile X Syndrome.
“The impaired ERP habituation in mice is similar to the deficits observed in humans with FXS.”
Quote in the paperSubstantial claim - Premisecitation
MMP-9 translation is negatively regulated by FMRP.
“MMP-9 is an endopeptidase that can cleave extracellular matrix (Ethell and Ethell, 2007) and its translation is negatively regulated by FMRP (Janusz et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Janusz et al., 2013 source
Not checked in the free run.
- Interpretationown data
Abnormal MMP-9 regulation is a mechanism underlying auditory hypersensitivity in Fragile X Syndrome.
“suggest that abnormal MMP-9 regulation is a mechanism underlying auditory hypersensitivity in FXS.”
Quote in the paperSubstantial claim - Interpretationown data
Genetic deletion of Mmp-9 reverses the auditory event-related potential habituation deficits in Fmr1 knockout mice.
“whereas a genetic deletion of Mmp-9 reverses ERP habituation deficits in Fmr1 KO mice.”
Quote in the paperSubstantial claim - Premisecitation
Humans with Fragile X Syndrome show reduced habituation of the auditory event-related potential N1 component with sound repetition compared with controls.
“A consistent observation in FXS is that the amplitude of the N1 component of auditory event related potentials (ERP) shows reduced habituation with sound repetition compared to the control group, suggesting neural correlates of auditory hypersensitivity.”
Quote in the paperSubstantial claim - Interpretationown data
Genetic deletion of Mmp-9 in Fmr1 knockout mice reverses the steady-state N1 habituation deficit.
“Taken together, these results indicate that at steady state, normalized N1 amplitudes are higher in the Fmr1 KO mice compared to WT mice and a genetic deletion of Mmp-9 in Fmr1 KO mice reverses this steady state habituation deficit.”
Quote in the paperSubstantial claim - Premisecitation
Increased UP states are observed in the somatosensory cortex of Fmr1 knockout mice.
“This is consistent with increased UP states observed in the somatosensory cortex of Fmr1 KO mice (Gibson et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gibson et al., 2008 source
Not checked in the free run.
- Interpretationown data
Auditory event-related potential habituation is a translation-relevant physiological pre-clinical marker of auditory processing deficits in Fragile X Syndrome.
“Together these data establish ERP habituation as a translation relevant, physiological pre-clinical marker of auditory processing deficits in FXS”
Quote in the paperSubstantial claim - Interpretationreasoning
Weaker inhibition after an excitatory sound response is predicted to reduce habituation.
“Weaker inhibition following an excitatory response to a sound is predicted to result in reduced habituation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Reduced PV-dependent inhibition in auditory cortex may cause the sustained responses in Fmr1 KO neurons.
“Thus reduced PV-dependent inhibition in the auditory cortex may result in the sustained responses in Fmr1 KO neurons.”
Quote in the paperNot a substantial claim - Interpretationown data
This indicates a higher steady-state auditory cortex response in Fmr1 KO mice during repeated stimulation.
“This indicates a higher steady state response in the auditory cortex of Fmr1 KO mice with repeated stimulation.”
Quote in the paperSubstantial claim - Interpretationown data
Abnormally high MMP-9 may contribute to auditory processing deficits in FXS.
“suggesting that abnormally high levels of MMP-9 may contribute to auditory processing deficits in FXS.”
Quote in the paperSubstantial claim - Premisecitation
Fmr1 KO neurons also had broader frequency tuning curves.
“Fmr1 KO neurons also showed broader frequency tuning curves.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rotschafer and Razak, 2013
Not checked in the free run.
- Premisereasoning
Recovery dynamics of cortical neurons to repeated stimuli would depend at least partly on this delayed inhibition and on synaptic depression.
“The recovery dynamics of cortical neurons to repeated stimuli would at least partly depend on this delayed inhibition in addition to factors such as synaptic depression.”
Quote in the paperNot a substantial claim - Interpretationcitation
The absence of N1 latency differences between Fmr1 KO and WT recordings is consistent with human observations (Van der Molen et al., 2012a,b).
“Likewise, the lack of differences in N1 latency between Fmr1 KO and WT recordings is consistent with observations in humans (Van der Molen et al., 2012a,b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Van der Molen et al., 2012a,b
Not checked in the free run.
- Rests on an assumption: The Fmr1 KO mouse is a valid model for human FXS auditory phenotypes.
- Rests on an assumption: N1 ERP habituation in mice and humans reflects the same underlying neural process.
- Premisecitation
The delayed synaptic inhibition comes from fast-spiking interneurons, putatively parvalbumin-expressing (Wu et al., 2008).
“The delayed synaptic inhibition is generated by fast spiking interneurons, putatively expressing parvalbumin (PV, Wu et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al., 2008
Not checked in the free run.
- Premisecitation
The phasic onset response and the lack of sustained cortical response depend on inhibitory input delayed relative to excitatory input (Wehr and Zador, 2003, Wu et al., 2008).
“The phasic onset response and the lack of sustained response in cortical neurons depend on an inhibitory input that is delayed relative to the excitatory input (Wehr and Zador, 2003, Wu et al., 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wehr and Zador, 2003
Not checked in the free run.
- cites Wu et al., 2008
Not checked in the free run.
- Premisecitation
The steady-state reduction in response to later train stimuli is thought to reflect refractory/recovery dynamics of auditory neurons and circuits (Fruhstorfer et al., 1970; Karhu et al., 1997).
“The reduction in response to subsequent stimuli in the train over the steady state is thought to reflect refractory/recovery dynamics of neurons and circuits of the auditory system (Fruhstorfer et al., 1970; Karhu et al., 1997).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
The steady-state habituation deficit in Fmr1 KO mice relative to WT is unlikely to be explained by N1 peak latency variability, since no such variability differences were seen between these genotypes.
“However, the deficit in steady state habituation in Fmr1 KO mice compared to WT mice is unlikely related to differences in variability of N1 peak latency, which were not observed between those genotypes.”
Quote in the paperNot a substantial claim - Interpretationown data
Fmr1 KO mice show normal sensory gating.
“suggesting normal sensory gating in Fmr1 KO mice.”
Quote in the paperSubstantial claim - Interpretationown data
This impaired reduction suggests a deficit in refractory/recovery dynamics in FXS.
“suggesting a deficit in the refractory/recovery dynamics in FXS.”
Quote in the paperSubstantial claim - Interpretationown data
Auditory hypersensitivity in humans with FXS may result from constantly elevated responses in a repetitive acoustic environment.
“These results suggest that auditory hypersensitivity observed in humans with FXS may be due to constantly elevated response in a repetitive acoustic environment.”
Quote in the paperSubstantial claim - Interpretationreasoning
The reversal of habituation deficits in Mmp-9/Fmr1 DKO mice suggests minocycline may act by reducing MMP-9 in the human FXS auditory system.
“The reversal of habituation deficits in Mmp-9/Fmr1 DKO mice in the present study suggest that minocycline may indeed act by reducing MMP-9 levels in the auditory system of humans with FXS.”
Quote in the paperSubstantial claim - Interpretationown data
Abnormal MMP-9 levels in Fmr1 KO auditory cortex suggest the ERP habituation deficit may have a local cortical origin.
“The abnormal levels of MMP-9 in the auditory cortex of the Fmr1 KO mice suggest that the ERP habituation deficit may have a local cortical origin.”
Quote in the paperSubstantial claim - Interpretationcitation
Auditory cortical ERP habituation is reduced in Fmr1 KO mice analogously to human FXS.
“Auditory cortical ERP habituation is reduced in Fmr1 KO mice in a manner analogous to that seen in humans with FXS.”
Quote in the paperSubstantial claim- Rests on an assumption: The Fmr1 KO mouse is a valid model for human FXS auditory phenotypes.
- Rests on an assumption: N1 ERP habituation in mice and humans reflects the same underlying neural process.
- Premisecitation
Minocycline, which lowers MMP-9 activity and levels, reduces ERP habituation deficits in humans with FXS (Schneider et al., 2013).
“Treatment with minocycline, which reduces MMP-9 activity and levels, reduces ERP habituation deficits humans with FXS (Schneider et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schneider et al., 2013 source
Not checked in the free run.
- Premisecitation
MMP-9 levels are high in cortex and hippocampus of humans with FXS and Fmr1 KO mice (Sidhu et al., 2014; Gkogkas et al., 2014).
“MMP-9 levels are high in the cortex and hippocampus of humans with FXS and Fmr1 KO mice (Sidhu et al., 2014; Gkogkas et al., 2014).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Stabilization of PNNs around PV interneurons after Mmp-9 deletion may cause the reversal of habituation deficits in DKO mice.
“Stabilization of PNN around PV interneurons due to a genetic deletion of Mmp-9 may be responsible for the reversal of habituation deficits in Mmp-9/Fmr1 DKO mice.”
Quote in the paperSubstantial claim
- May combine two claims. 44
- Classified as probably not a substantial claim. 27
May combine two claims.
Findingown dataIn all three genotypes, auditory event-related potentials habituate by the second sound in the train, with no statistical difference between genotypes.
“This indicates that ERPs in all three genotypes of mice habituate to auditory stimuli by the second sound in the train and there is no statistical difference between the genotypes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe normalized first N1 response does not differ by genotype, repetition rate, or their interaction.
“Two-way ANOVA of genotype and repetition rate reveals no differences for the normalized 1st response between genotype (F(2,123) = 1.482, p = 0.231), repetition rate (F(5,123) = 0.593, p = 0.216), or genotype x repetition rate interaction (F(10,123) = 0.593, p = 0.817) (Figure 2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataN1 latency differs between wildtype and Mmp-9/Fmr1 double knockout mice, but not between wildtype and Fmr1 knockout mice or between double knockout and Fmr1 knockout mice.
“Post-hoc Bonferroni analysis reveals a difference between WT and Mmp-9/Fmr1 DKO (p = 0.002), but not between WT and Fmr1 KO (p = 0.171), or Mmp-9/Fmr1 DKO and Fmr1 KO mice (p = 0.204).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRaw N1 amplitudes in Mmp-9 knockout mice do not differ from wildtype mice except at 0.25 Hz, where they are lower.
“Additionally, raw amplitudes of Mmp-9 KO mice showed no difference when compared to WT mice using independent samples t-test (all p > 0.5), except at the lowest rate of 0.25Hz, which was significantly lower than WT, p = 0.046 (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataN1 latency shows a main effect of genotype but not of repetition rate or their interaction.
“Two-way ANOVA on N1 latency of genotype and rate shows a main effect of genotype (F(2,118) = 6.369, p = 0.002), but not of rate (F(5,118) = 2.247, p = 0.054), or genotype x rate interaction (F(10,118) = 0.742, p = 0.683).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe second N1 response does not differ between genotypes, but it does differ by repetition rate, with greater habituation at faster rates in all genotypes.
“A two-way ANOVA of genotype and repetition rate reveals no differences for the 2nd response between genotype (F(2,123) = 2.500, p = 0.086) or a genotype x repetition rate interaction (F(10,123) = 0.746, p = 0.680). However, 2nd responses are different depending on the repetition rate (F(5,123) = 13.898, p < 0.000001), with more habituation occurring at faster rates for all genotypes (Figure 2F).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe Fano factor of N1 latency differs in Mmp-9/Fmr1 double knockout mice compared with wildtype or Fmr1 knockout mice, with no difference between wildtype and Fmr1 knockout mice.
“Post-hoc Bonferroni analysis shows that differences in Fano Factor existed in Mmp-9/Fmr1 DKO mice when compared to WT or Fmr1 KO mice (p = 0.009), with no differences between WT and Fmr1 KO mice (p = 0.9).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Fano factor of N1 latency shows effects of genotype and repetition rate but no genotype-by-rate interaction.
“The analysis showed that there was an effect of genotype (F(2,117) = 6.953, p = 0.001), and an effect of repetition rate (F(5,117) = 13.152, p < 0.000001), with no genotype x repetition rate interaction (F(10,117) = 0.845, p = 0.587).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAt 0.25 Hz, N1 latency was stable across the whole stimulus train in WT, Fmr1 KO, and Mmp-9/Fmr1 DKO mice, and no genotype differences were found (F(2,20)=0.308, p=0.738).
“At 0.25 Hz N1 latencies were extremely stable throughout the entire stimulus train for WT (Fano Factor: 0.00019 ± 0.00008, n = 7), Fmr1 KO (Fano Factor: 0.00052 ± 0.00046, n = 9), and Mmp-9/Fmr1 DKO mice (Fano Factor: 0.00028 ± 0.00024) with no differences observed between genotypes (F(2,20) = 0.308, p = 0.738)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFmr1 KO mice had a habituation deficit across repeated sounds at 5 Hz, but no differences were observed in responses to the deviant noise or the following tone.
“These results indicate that while Fmr1 KO mice have a deficit in habituation across repeated sounds for a 5 Hz repetition rate, no differences in response to the deviant noise or the tone following the deviant noise were observed.”
Quote in the paperSubstantial claim- Rests on an assumption: The fixed-position deviant sound paradigm is adequate to detect stimulus contrast detection deficits in Fmr1 KO mice.
May combine two claims.
Findingown dataIndependent t-tests on each train stimulus showed some WT versus Fmr1 KO and DKO versus Fmr1 KO differences, but no WT versus DKO difference at any position (p>0.05).
“Comparison of the responses to each stimulus in the train in isolation using independent samples t-tests revealed some differences between WT and Fmr1 KO mice and between Mmp-9/Fmr1 DKO and Fmr1 KO mice (Figure 6A), but no difference between WT and Mmp-9/Fmr1 DKO at any position (p>0.05).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPost-hoc tests attributed the genotype effect to differences between Fmr1 KO and WT or DKO mice (p<0.000001), with no WT versus DKO difference (p=0.9).
“Post-hoc analysis showed that the effect of genotype is due to the differences between Fmr1 KO mice and WT or Mmp-9/Fmr1 DKO mice (p < 0.000001), but no differences between WT and Mmp-9/Fmr1 DKO mice (p = 0.9).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNo early-train differences appeared between genotypes, consistent with similar early habituation, while impaired responses occurred only in Fmr1 KO mice during later steady-state habituation.
“It should also be noted that no differences are seen early in the train between any genotypes, which is consistent with earlier results showing similar early habituation between genotypes, but impaired responses only in Fmr1 KO genotype during later, steady state habituation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataResponses reached a stable asymptote after two to three repetitions, but the asymptote amplitude was significantly higher in Fmr1 KO than WT mice.
“The responses asymptote to a stable level after the first two to three repetitions, but the asymptote amplitude was significantly higher in Fmr1 KO than WT mice.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt some repetition rates, Mmp-9/Fmr1 DKO mice had larger N1 amplitudes, shorter latencies, and less latency variability.
“at some rates, the N1 amplitudes were larger, and latencies shorter and less variable, in the Mmp-9/Fmr1 DKO mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSound-evoked cortical N1 amplitudes decreased rapidly and in a repetition-rate-dependent way in all three genotypes.
“Sound evoked cortical N1 amplitudes showed a rapid and repetition rate-dependent reduction across all three genotypes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn all three genotypes, the second response to a paired sound was reduced relative to the first, with no significant genotype difference.
“The response amplitude to the second sound of a pair is normally reduced compared to the first. This was seen in all three genotypes with no significant difference between them suggesting normal sensory gating in Fmr1 KO mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDiscrimination indices for the 5th-6th and 6th-7th transitions showed no differences (F(2,18)=0.725, p=0.498; F(2,18)=0.255, p=0.778).
“No differences were observed for either 5th −6th transition (F(2,18) = 0.725, p = 0.498) or from 6th-7th transition (F(2,18) = 0.255, p = 0.778)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRemoval of MMP-9 in Mmp9 KO mice mostly did not affect auditory ERP N1 amplitude or habituation, although MMP-9 is involved in sensory system development (Reinhard et al., 2015).
“Although MMP-9 is involved in sensory system development (reviewed in Reinhard et al., 2015), we found that auditory ERP N1 amplitude and habituation are mostly unaffected by the removal of MMP-9 (Mmp9 KO mice).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Reinhard et al., 2015 source
Not checked in the free run.
May combine two claims.
Findingown dataIn that paradigm, there was a main effect of genotype (F(2,162)=30.631, p<0.000001) and no genotype by position interaction (F(16,162)=0.725, p=0.766).
“Additionally, a main effect of genotype was found (F(2,162) = 30.631, p < 0.000001), with no genotype x position interaction (F(16,162) = 0.725, p = 0.766).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNot all ERP properties were similar between Mmp-9/Fmr1 DKO and WT mice; DKO mice had shorter N1 latencies at 0.25 and 0.5 Hz, smaller latency variance, and higher N1 amplitude than WT and Fmr1 KO mice at some rates.
“It must be noted that not all ERP properties were similar between the Mmp-9/Fmr1 DKO and WT mice. Mmp-9/Fmr1 DKO mice had shorter N1 latencies at the slowest (0.25 and 0.5 Hz) repetition rates, smaller variance in latency and higher N1 amplitude than the WT and Fmr1 KO mice for some repetition rates.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWT and Fmr1 KO mice did not differ significantly in N1 amplitude or latency.
“there were no significant differences in N1 amplitude or latency between the WT and Fmr1 KO mice”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMMP-9 is an endopeptidase that can cleave extracellular matrix.
“MMP-9 is an endopeptidase that can cleave extracellular matrix (Ethell and Ethell, 2007)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ethell and Ethell, 2007
Not checked in the free run.
May combine two claims.
PremisecitationFmr1 knockout mice exhibit auditory hypersensitivity, including audiogenic seizures and enhanced cortical responses to sounds.
“Fmr1 knockout (KO) mouse, a pre-clinical model of FXS, also exhibits auditory hypersensitivity including audiogenic seizures (Chen and Toth, 2001; Musumeci et al., 2007) and enhanced cortical responses to sounds (Rotschafer and Razak, 2013).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Chen and Toth, 2001
Not checked in the free run.
- cites Musumeci et al., 2007 source
Not checked in the free run.
- cites Rotschafer and Razak, 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFragile X Syndrome results from expansion and hyper-methylation of CGG trinucleotide repeats in the FMR1 gene, leading to reduced FMRP.
“FXS results from expansion and hyper-methylation of CGG trinucleotide repeats in the un-translated 5’ region of the Fragile X Mental Retardation (FMR1) gene, leading to reduced FMR1 protein (FMRP) (Bailey et al., 1998; O'Donnell and Warren, 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Bailey et al., 1998 source
Not checked in the free run.
- cites O'Donnell and Warren, 2002
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationAuditory event-related potential habituation deficits in humans with Fragile X Syndrome are reversed by minocycline treatment.
“The ERP habituation deficits in humans with FXS are reversed by minocycline treatment but the underlying mechanisms are not known (Schneider et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schneider et al. 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationGenetic deletion of Mmp-9 in Fmr1 knockout mice reverses some molecular and physiological hippocampal deficits and Fragile X Syndrome-associated behaviors.
“Genetic deletion of Mmp-9 in Fmr1 KO mice reverses some molecular and physiological hippocampal deficits and FXS-associated behaviors (Sidhu et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sidhu et al., 2014 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenGenotypes were confirmed by PCR analysis of genomic DNA isolated from mouse tails.
“All genotypes were confirmed by PCR analysis of genomic DNA isolated from mouse tails.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe order of broadband noise stimulus trains at different repetition rates was selected at random.
“The order in which BBN stimulus trains with different repetition rates were presented was selected at random.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMinocycline can reduce the levels and activity of MMP-9.
“Beside its antibiotic and anti-inflammatory activity, minocycline can reduce the levels and activity of matrix metalloproteinase-9 (MMP-9) (Lee et al., 2006; Bilousova et al., 2009; Dziembowska et al 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSpeaker output fluctuation was within +/- 3 dB for frequencies between 5 and 35 kHz, as measured with a 1/4 inch B&K microphone.
“The speaker output fluctuation was within +/− 3 dB for frequencies between 5 and 35 kHz as measured using a ¼ inch B&K microphone.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningDifferences in repetition rates, anesthesia, and scalp versus cortical recordings may explain the human-mouse N1 amplitude discrepancy.
“Factors such as differences in repetition rates, anesthesia and scalp versus cortical recordings may contribute to these differences.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMismatch negativity amplitude is lower in humans with FXS (Van der Molen et al., 2012b).
“The amplitude of mismatch negativity is lower in humans with FXS (Van der Molen et al., 2012b)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Van der Molen et al., 2012b
Not checked in the free run.
May combine two claims.
PremisecitationThe second response in a stimulus train measures early habituation, a process linked to sensory gating (Rosburg et al., 2004).
“In response to a stimulus train, the amplitude of the second response in the train is a measure of early habituation, a process related to sensory gating (Rosburg et al., 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rosburg et al., 2004 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIf non-stimulus-driven artifacts occurred during a sound train, the entire train was removed from subsequent analysis.
“If during sound train presentation, non-stimulus driven artifacts were observed, the entire train was removed from subsequent analysis.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationWhen sound is repeated, more cortical neurons may be activated in a sustained way in Fmr1 KO mice due to reduced synaptic inhibition and enhanced intrinsic excitability, producing hyperexcitability in FXS.
“Thus when a sound is repeated, more neurons across the cortex may be activated in a sustained fashion in Fmr1 KO mice due to a combination of reduced synaptic inhibition and enhanced intrinsic excitability resulting in hyperexcitability in FXS.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationReduced N1 habituation in Fmr1 KO mice resembles human FXS observations, providing an analogous functional sensory outcome measure in mice and humans (Castren et al., 2003; Van der Molen et al., 2012; Schneider et al., 2013).
“The reduced habituation of N1 amplitude in Fmr1 KO mice is similar to observations in humans with FXS providing, for the first time, an analogous functional sensory outcome measure in mice and humans (Castren et al., 2003; Van der Molen et al., 2012; Schneider et al., 2013).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Castren et al., 2003 source
Not checked in the free run.
- cites Van der Molen et al., 2012
Not checked in the free run.
- cites Schneider et al., 2013 source
Not checked in the free run.
- Rests on an assumption: The Fmr1 KO mouse is a valid model for human FXS auditory phenotypes.
- Rests on an assumption: N1 ERP habituation in mice and humans reflects the same underlying neural process.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThis lower mismatch negativity may reflect reduced habituation of the steady-state response.
“that may also reflect a reduced habituation of steady state response.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe sustained response component was mostly absent in WT neurons but significant in Fmr1 KO neurons.
“The sustained component of the response, which was mostly absent in WT neurons, was significant in Fmr1 KO neurons.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rotschafer and Razak, 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationERP studies typically average hundreds of trials for high signal-to-noise; average amplitude differences can arise from different individual response amplitudes or from latency jitter smearing the average (Mouraux and Ionnetti, 2008).
“Averaging of 100s of trials is typically performed to obtain high signal to noise ratios in ERP studies. Using an averaging approach, differences in average amplitudes could be either because the individual responses have different amplitudes or because of increased latency jitter of individual responses, which then “smear” the average (Mouraux and Ionnetti, 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mouraux and Ionnetti, 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationReduced cortical GABA-A mediated inhibition in Fmr1 KO cortex may also contribute to broader tuning curves (Wang et al., 2000).
“Reduced cortical GABA-A mediated inhibition observed in Fmr1 KO cortex may also contribute to broader tuning curves in the Fmr1 KO mice (Wang et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al., 2000 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe data suggest that enhanced steady-state cortical activation during repeated acoustic stimulation may contribute to auditory hypersensitivity in FXS, and that abnormal MMP-9 levels may lead to that hypersensitivity.
“These data suggest that enhanced steady state cortical activation in the presence of repeated acoustic stimulation may contribute to auditory hypersensitivity in FXS and suggest that abnormal MMP-9 levels may lead to the auditory hypersensitivity in FXS.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThe higher average N1 amplitude in human FXS may relate to reduced habituation when responses are averaged over repetitions and to N1 latency variability.
“The higher average N1 amplitude in human FXS may be related to the reduced habituation when responses are averaged over multiple repetitions and variability of N1 latency”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn Fmr1 KO somatosensory cortex, PV neurons receive reduced excitatory drive, causing reduced network inhibition and increased UP states (Selby et al., 2007; Gibson et al., 2008).
“In the somatosensory cortex of Fmr1 KO mice, PV neurons receive reduced excitatory drive resulting in reduced inhibition in the network and increased UP states (Selby et al., 2007; Gibson et al., 2008).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningSmaller latency variance may increase N1 amplitude through greater synchrony.
“The smaller latency variance may contribute to the larger N1 amplitude because of increased synchrony.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAt each recording location, habituation and oddball testing began only after reliable sound-driven event-related potentials with an N1 component at about 45 ms latency were produced.
“At each recording location, habituation and oddball testing began only after sound-driven ERPs with an N1 component with ~45 ms latency could be reliably produced.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSound delivery was synchronized with EEG recording using a 5 ms digital TTL pulse to mark sound onset.
“Data were sampled at a rate of either 5 or 20 kHz using Acqknowledge software, and sound delivery was synchronized with EEG recording using a 5 ms digital TTL pulse to mark the onset of each sound in a train.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll mouse studies were done according to NIH and Institutional Animal Care and Use Committee guidelines.
“All mouse studies were done according to NIH and Institutional Animal Care and Use Committee guidelines.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationA prior in vivo auditory cortex study found hyper-responsive neurons in Fmr1 KO mice (Rotschafer and Razak, 2013).
“A previous in vivo study of the auditory cortex revealed hyper-responsive neurons in Fmr1 KO mice (Rotschafer and Razak, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rotschafer and Razak, 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenToe pinch reflex was used to measure anesthetic state every 20-30 minutes and isoflurane levels were adjusted as needed.
“Toe pinch reflex was used to measure anesthetic state every 20–30 minutes throughout the experiment, and isoflurane levels were adjusted as needed.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataMmp-9/Fmr1 DKO mice had habituation responses similar to WT, indicating that deleting Mmp-9 reversed the Fmr1 KO deficit at 5 Hz.
“Habituation responses in Mmp-9/Fmr1 DKO mice were similar to WT, indicating that a genetic deletion of Mmp-9 reversed the deficits in Fmr1 KO mice at a stimulus repetition rate of 5 Hz.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe smaller N1 latency Fano factor in DKO recordings suggests latency jitter may explain their larger N1 amplitude.
“The smaller N1 latency Fano factor of the Mmp-9/Fmr1 DKO recordings suggest the latter may be the reason here.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenThe location of core auditory cortex was identified using vasculature and confirmed with extracellular recordings in response to sounds.
“Location of core auditory cortex was identified using vasculature, and confirmed with extracellular recordings in response to sounds.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationRecovery windows during repeated auditory cortex stimulation may also depend on intrinsic excitability and presynaptic BK channel deficits in Fmr1 KO mice (Deng et al., 2013), contributing to the habituation phenotype.
“Recovery windows during repeated stimulation in the auditory cortex may also depend on intrinsic excitability and deficits in presynaptic BK channels in Fmr1 KO mice (Deng et al., 2013) contributing to the habituation phenotype.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Deng et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe amplifier gain was kept the same at 10,000x between all recordings.
“Normal EEG output data was collected, alpha detection mode was not used and gain was kept the same (10,000×) between all recordings.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAlthough ERPs have low spatial resolution for circuit, cortical depth, or single-neuron mechanisms, the human-mouse similarity in habituation deficits provides a translation-relevant functional biomarker.
“Although ERPs have low spatial resolution to address mechanisms at the circuit, cortical depth or single neuron level, the similarity of the habituation deficits between humans and mice provides a functional biomarker that is translation relevant.”
Quote in the paperSubstantial claim- Rests on an assumption: The Fmr1 KO mouse is a valid model for human FXS auditory phenotypes.
- Rests on an assumption: N1 ERP habituation in mice and humans reflects the same underlying neural process.
May combine two claims.
PremisecitationFMRP is expressed throughout the auditory system, and the cortical habituation deficits may have multiple origins (Strumbos et al., 2010; Wang et al., 2014; Rotschafer et al., 2015).
“However, FMRP is expressed across the auditory system and the observed cortical habituation deficits may have multiple origins (Strumbos et al., 2010; Wang et al., 2014; Rotschafer et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationAbnormally high or low MMP-9 levels may cause auditory circuit differences.
“and abnormally high or low levels may result in auditory circuit differences.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDeleting MMP-9 from Fmr1 KO mice reverses molecular and synaptic hippocampal deficits and some FXS-associated behaviors (Sidhu et al., 2014).
“Deletion of MMP-9 from Fmr1 KO mice results in reversal of molecular and synaptic deficits in the hippocampus of Fmr1 KO mice as well as some FXS-associated behaviors (Sidhu et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sidhu et al., 2014 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningBecause similar sensory processing deficits occur in FXS and ASD, auditory ERP habituation may serve as a broader preclinical model for drug discovery in autism.
“Given that similar sensory processing deficits are seen in FXS and ASD, auditory ERP habituation may serve more broadly as a pre-clinical model for drug discovery in autism.”
Quote in the paperNot a substantial claim- Rests on an assumption: The Fmr1 KO mouse is a valid model for human FXS auditory phenotypes.
- Rests on an assumption: N1 ERP habituation in mice and humans reflects the same underlying neural process.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMMP-9 regulates normal sensory cortex development (Kaliszewska et al., 2012).
“MMP-9 regulates normal development of sensory cortex (Kaliszewska et al., 2012)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kaliszewska et al., 2012 source
Not checked in the free run.
May combine two claims.
InterpretationcitationHigh MMP-9 may reduce PNN formation around PV interneurons, affecting their activity (Cabungcal et al., 2013), leading to impaired inhibition (Selby et al., 2007; Gibson et al., 2008) and enhanced excitability in Fmr1 KO auditory cortex.
“High MMP-9 levels may result in reduced PNN formation around PV interneurons affecting their activity (Cabungcal et al., 2013) and leading to impaired inhibition (Selby et al., 2007; Gibson et al., 2008), and enhanced excitability in Fmr1 KO auditory cortex.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Premisenone givenMMP-9 targets perineuronal nets (PNNs), which preferentially surround PV-expressing inhibitory interneurons in cortex.
“MMP-9 targets components of the extracellular matrix known as perineuronal nets (PNNs), which preferentially surround PV-expressing inhibitory interneurons in the cortex.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The mechanisms underlying auditory event-related potential habituation deficits in Fragile X Syndrome are not known.
“However, the mechanisms underlying ERP habituation deficits are not known.”
The paper relies on this without support.
The mechanisms by which minocycline reverses auditory event-related potential habituation deficits in Fragile X Syndrome are not known.
“The ERP habituation deficits in humans with FXS are reversed by minocycline treatment but the underlying mechanisms are not known (Schneider et al. 2013).”
The paper relies on this without support.
The Fmr1 KO mouse is a valid model for human FXS auditory phenotypes.
“The reduced habituation of N1 amplitude in Fmr1 KO mice is similar to observations in humans with FXS providing, for the first time, an analogous functional sensory outcome measure in mice and humans”
The paper relies on this without support.
N1 ERP habituation in mice and humans reflects the same underlying neural process.
“Auditory cortical ERP habituation is reduced in Fmr1 KO mice in a manner analogous to that seen in humans with FXS.”
The paper relies on this without support.
The fixed-position deviant sound paradigm is adequate to detect stimulus contrast detection deficits in Fmr1 KO mice.
“The deviant sound paradigm in this study, however, did not reveal differences between genotypes except for abnormal habituation for the 5 Hz rate in Fmr1 KO mice.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mature Fmr1 KO mouse auditory cortex exhibits reduced habituation to repeated sound presentations.
“Recent work using EEG/ERP recordings shows that mature Fmr1 KO mouse auditory cortex exhibits reduced habituation to repeated sound presentations (Lovelace et al., 2016).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Lovelace et al., 2016
Removing MMP-9 reverses multiple FXS phenotypes in Fmr1 knock-out mice, among them poor habituation of auditory responses.
“MMP-9 deletion reverses several FXS phenotypes in Fmr1 KO mice (Sidhu et al. 2014), including impaired auditory response habituation (Lovelace et al. 2016).”
From Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice (2018) · cites this paper as Lovelace et al. 2016
Earlier work found hyperexcitable auditory cortex responses and poor habituation to repeated sounds in adult Fmr1 knock-out mice, pointing to an excitation/inhibition imbalance.
“Our previous studies showed hyperexcitable auditory cortical responses (Rotschafer and Razak 2013) and impaired habituation to repeated sounds in adult Fmr1 KO mice (Lovelace et al. 2016), suggesting impaired E/I balance.”
From Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice (2018) · cites this paper as Lovelace et al. 2016
Similar sensory deficits are observed in adult Fmr1 knock-out mice and are reversed by genetic deletion of MMP-9.
“Similar sensory deficits are also observed in adult Fmr1 knock-out (KO) mice and are reversed by genetic deletion of Matrix Metalloproteinase-9 (MMP-9) through yet unknown mechanisms.”
From Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice (2018) · cites this paper as Lovelace et al. 2016
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Inconsistent p-value: F(5,123) = 0.593, p = .216
MinorThe paper reports p = .216 here; recomputing from the test statistic and its degrees of freedom gives p = .705. The check cannot tell whether the statistic or the p-value is the misprint.
Reported p = .216 · recomputed p = .705
“F(5,123) = 0.593, p = 0.216”
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upF(5, 123) = 0.593reported p = .216 · recomputed p = .705
“F(5,123) = 0.593, p = .216”
- Consistentt(8) = 4.65reported p = .0016 · recomputed p = .002
“t(8) = 4.65, p = .0016”
- Consistentt(8) = 0.13reported p = .8983 · recomputed p = .900
“t(8) = 0.13, p = .8983”
- ConsistentF(5, 119) = 13.194reported p < .000001 · recomputed p < .001
“F(5,119) = 13.194, p < .000001”
- ConsistentF(2, 119) = 16.344reported p < .000001 · recomputed p < .001
“F(2,119) = 16.344, p < .000001”
- ConsistentF(10, 119) = 1.013reported p = .437 · recomputed p = .437
“F(10,119) = 1.013, p = .437”
- ConsistentF(2, 123) = 1.482reported p = .231 · recomputed p = .231
“F(2,123) = 1.482, p = .231”
- ConsistentF(10, 123) = 0.593reported p = .817 · recomputed p = .817
“F(10,123) = 0.593, p = .817”
- ConsistentF(2, 123) = 2.5reported p = .086 · recomputed p = .086
“F(2,123) = 2.500, p = .086”
- ConsistentF(10, 123) = 0.746reported p = .68 · recomputed p = .680
“F(10,123) = 0.746, p = .680”
- ConsistentF(5, 123) = 13.898reported p < .000001 · recomputed p < .001
“F(5,123) = 13.898, p < .000001”
- ConsistentF(2, 99) = 12.561reported p < .00002 · recomputed p < .001
“F(2,99) = 12.561, p < .00002”
- ConsistentF(4, 99) = 46.394reported p < .000001 · recomputed p < .001
“F(4,99) = 46.394, p < .000001”
- ConsistentF(8, 99) = 0.471reported p = .874 · recomputed p = .874
“F(8,99) = 0.471, p = .874”
- ConsistentF(2, 118) = 6.369reported p = .002 · recomputed p = .002
“F(2,118) = 6.369, p = .002”
- ConsistentF(5, 118) = 2.247reported p = .054 · recomputed p = .054
“F(5,118) = 2.247, p = .054”
- ConsistentF(10, 118) = 0.742reported p = .683 · recomputed p = .684
“F(10,118) = 0.742, p = .683”
- Consistentt(12) = 2.577reported p = .024 · recomputed p = .024
“t(12) = 2.577, p = .024”
- Consistentt(12) = 3.558reported p = .004 · recomputed p = .004
“t(12) = 3.558, p = .004”
- ConsistentF(2, 117) = 6.953reported p = .001 · recomputed p = .001
“F(2,117) = 6.953, p = .001”
- ConsistentF(5, 117) = 13.152reported p < .000001 · recomputed p < .001
“F(5,117) = 13.152, p < .000001”
- ConsistentF(10, 117) = 0.845reported p = .587 · recomputed p = .587
“F(10,117) = 0.845, p = .587”
- ConsistentF(2, 20) = 0.308reported p = .738 · recomputed p = .738
“F(2,20) = 0.308, p = .738”
- ConsistentF(8, 162) = 14.289reported p < .000001 · recomputed p < .001
“F(8,162) = 14.289, p < .000001”
- ConsistentF(2, 162) = 30.631reported p < .000001 · recomputed p < .001
“F(2,162) = 30.631, p < .000001”
- ConsistentF(16, 162) = 0.725reported p = .766 · recomputed p = .766
“F(16,162) = 0.725, p = .766”
- ConsistentF(2, 18) = 0.725reported p = .498 · recomputed p = .498
“F(2,18) = 0.725, p = .498”
- ConsistentF(2, 18) = 0.255reported p = .778 · recomputed p = .778
“F(2,18) = 0.255, p = .778”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
ANOVA implies more observations than the reported recording sites allow
MinorWith three genotypes and six repetition rates, a two-way ANOVA with 123 residual degrees of freedom requires 141 observations. The reported 7 WT, 9 Fmr1 KO, and 7 double-KO recording sites could provide at most 138 site-by-rate observations.
“Two-way ANOVA of genotype and repetition rate reveals no differences for the normalized 1st response between genotype (F(2,123) = 1.482, p = 0.231), repetition rate (F(5,123) = 0.593, p = 0.216), or genotype x repetition rate interaction (F(10,123) = 0.593, p = 0.817) (Figure 2E).”
“resulting in 7 recording sites in WT mice, 9 recording sites in Fmr1 KO mice, 10 recording sites in Mmp-9 KO mice and 7 recording sites in Mmp-9/Fmr1 DKO mice.”
Cites
The mouse brain in stereotaxic coordinates
Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796 · see citing works
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Lai, M.-C., Lombardo, M. V., & Baron-Cohen, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61539-1 · Cited by 2,371 · see citing works
Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex
Wehr, M., & Zador, A. M. (2003) · Nature · doi:10.1038/nature02116 · Cited by 1,363 · see citing works
Gibson, J. R., Bartley, A. F., Hays, S. A., & Huber, K. M. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90752.2008 · Cited by 529 · see citing works
Perineuronal nets protect fast-spiking interneurons against oxidative stress
Cabungcal, J.-H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., & Do, K. Q. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300454110 · Cited by 512 · see citing works
A Decade of Molecular Studies of Fragile X Syndrome
O'Donnell, W. T., & Warren, S. T. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142909 · Cited by 481 · see citing works
Bilousova, T. V., Dansie, L., Ngo, M., Aye, J., Charles, J. R., Ethell, D. W., & Ethell, I. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061796 · Cited by 465 · see citing works
Self-citationAcross-trial averaging of event-related EEG responses and beyond
Mouraux, A., & Iannetti, G. D. (2008) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2008.01.011 · Cited by 437 · see citing works
Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Ethell, I. M., & Ethell, D. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21273 · Cited by 378 · see citing works
Self-citationDeng, P.-Y., Rotman, Z., Blundon, J. A., Cho, Y., Cui, J., Cavalli, V., Zakharenko, S. S., & Klyachko, V. A. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.018 · Cited by 354 · see citing works
Fragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345 · see citing works
Hagerman, R. J., & Hagerman, P. J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70125-x · Cited by 315 · see citing works
Neurobiology of Sensory Overresponsivity in Youth With Autism Spectrum Disorders
Green, S. A., Hernandez, L. M., Tottenham, N., Krasileva, K. E., Bookheimer, S. Y., & Dapretto, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0737 · Cited by 286 · see citing works
Lateral Sharpening of Cortical Frequency Tuning by Approximately Balanced Inhibition
Wu, G. K., Arbuckle, R., Liu, B., Tao, H. W., & Zhang, L. I. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.035 · Cited by 276 · see citing works
Autistic behavior in young boys with fragile X syndrome
Bailey, D. B., Mesibov, G. B., Hatton, D. D., Clark, R. D., Roberts, J. E., & Mayhew, L. (1998) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1026048027397 · Cited by 260 · see citing works
Short-term habituation of the auditory evoked response in man
Fruhstorfer, H., Soveri, P., & Järvilehto, T. (1970) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(70)90183-5 · Cited by 259 · see citing works
Selby, L., Zhang, C., & Sun, Q.-Q. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.062 · Cited by 245 · see citing works
An analysis of autism in fifty males with the fragile X syndrome
Hagerman, R. J., Jackson, A. W., Levitas, A., Rimland, B., Braden, M., Opitz, J. M., & Reynolds, J. F. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320230128 · Cited by 238 · see citing works
Reinhard, S. M., Razak, K., & Ethell, I. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00280 · Cited by 219 · see citing works
Self-citationGkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201 · see citing works
Hagerman, R. J., Amiri, K. M. A., & Cronister, A. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320380223 · Cited by 165 · see citing works
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
Dziembowska, M., Pretto, D. I., Janusz, A., Kaczmarek, L., Leigh, M. J., Gabriel, N., Durbin‐Johnson, B., Hagerman, R. J., & Tassone, F. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36023 · Cited by 161 · see citing works
Sidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155 · see citing works
Self-citationGABA-A antagonist causes dramatic expansion of tuning in primary auditory cortex
Wang, J., Caspary, D., & Salvi, R. J. (2000) · NeuroReport · doi:10.1097/00001756-200004070-00045 · Cited by 145 · see citing works
Altered auditory processing in a mouse model of fragile X syndrome
Rotschafer, S. E., & Razak, K. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.038 · Cited by 138 · see citing works
Self-citationStrumbos, J. G., Brown, M. R., Kronengold, J., Polley, D. B., & Kaczmarek, L. K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-10.2010 · Cited by 135 · see citing works
Augmentation of auditory N1 in children with fragile X syndrome.
Castrén, M., Pääkkönen, A., Tarkka, I. M., Ryynänen, M., & Partanen, J. (2003) · Brain Topography · doi:10.1023/a:1022606200636 · Cited by 123 · see citing works
Roberts, J. E., Price, J. R., Barnes, E., Nelson, L. M., Burchinal, M., Hennon, E. A., Moskowitz, L. J., Edwards, A., Malkin, C., Anderson, K. L., et al. (2007) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2007)112[177:rvevas]2.0.co;2 · Cited by 115 · see citing works
The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.
Janusz, A., Miłek, J., Perycz, M., Pacini, L., Bagni, C., Kaczmarek, L., & Dziembowska, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2207-13.2013 · Cited by 112 · see citing works
Electrocortical changes associated with minocycline treatment in fragile X syndrome
Schneider, A., Leigh, M. J., Adams, P., Nanakul, R., Chechi, T., Olichney, J., Hagerman, R., & Hessl, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113494105 · Cited by 108 · see citing works
Auditory Processing in Fragile X Syndrome
Rotschafer, S. E., & Razak, K. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00019 · Cited by 103 · see citing works
Self-citationAuditory change detection in fragile X syndrome males: A brain potential study
van der Molen, M. J. W., van der Molen, M. W., Ridderinkhof, K. R., Hamel, B. C. J., Curfs, L., & Ramakers, G. J. A. (2011) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.11.039 · Cited by 90 · see citing works
Van der Molen, M. J. W., Van der Molen, M. W., Ridderinkhof, K. R., Hamel, B. C. J., Curfs, L. M. G., & Ramakers, G. J. A. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.08.023 · Cited by 88 · see citing works
Lee, C. Z., Yao, J. S., Huang, Y., Zhai, W., Liu, W., Guglielmo, B. J., Lin, E., Yang, G.-Y., & Young, W. L. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600268 · Cited by 78 · see citing works
Parvalbumin immunoreactivity in the auditory cortex of a mouse model of presbycusis.
Martin del Campo, H. N., Measor, K. R., & Razak, K. A. (2012) · Hearing Research · doi:10.1016/j.heares.2012.08.017 · Cited by 76 · see citing works
Self-citationDual cerebral processing of elementary auditory input in children
Karhu, J., Herrgård, E., Pääkkönen, A., Luoma, L., Airaksinen, E., & Partanen, J. (1997) · NeuroReport · doi:10.1097/00001756-199704140-00002 · Cited by 76 · see citing works
Deletion of Fmr1 alters function and synaptic inputs in the auditory brainstem
Rotschafer, S. E., Marshak, S., & Cramer, K. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117266 · Cited by 72 · see citing works
Musumeci, S. A., Calabrese, G., Bonaccorso, C. M., D'Antoni, S., Brouwer, J. R., Bakker, C. E., Elia, M., Ferri, R., Nelson, D. L., Oostra, B. A., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.007 · Cited by 70 · see citing works
Yu, T. W., & Berry‐Kravis, E. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1386764 · Cited by 58 · see citing works
P3 Abnormality in fragile X syndrome
Clair, D. M. S., Blackwood, D., Oliver, C., & Dickens, P. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90148-x · Cited by 56 · see citing works
Short-term habituation of the intracranially recorded auditory evoked potentials P50 and N100
Rosburg, T., Trautner, P., Korzyukov, O. A., Boutros, N. N., Schaller, C., Elger, C. E., & Kurthen, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.047 · Cited by 55 · see citing works
Kaliszewska, A., Bijata, M., Kaczmarek, L., & Kossut, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr303 · Cited by 55 · see citing works
Wang, Y., Sakano, H., Beebe, K., Brown, M. R., de Laat, R., Bothwell, M., Kulesza, R. J., & Rubel, E. W. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23520 · Cited by 40 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
MMPs in learning and memory and neuropsychiatric disorders
Beroun, A., Mitra, S., Michaluk, P., Pijet, B., Stefaniuk, M., & Kaczmarek, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03180-8 · Cited by 207 · see citing works
Ethridge, L. E., White, S. P., Mosconi, M. W., Wang, J., Byerly, M. J., & Sweeney, J. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.48 · Cited by 188 · see citing works
Sinclair, D., Oranje, B., Razak, K. A., Siegel, S. J., & Schmid, S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.029 · Cited by 198 · see citing works
“…deficits in humans and animal models (Castrén et al., 2003; Connolly et al., 2004; Ehrlichman et al., 2008; Ethridge et al., 2016; Harms et al., 2014; Lovelace et al., 2016; Maxwell et al., 2004; Nakamura et al., 2011; Siegel et al., 2003; Umbricht et al., 2004) and have facilitated examination of…”
InfluentialSelf-citationCortical interneurons in autism
Contractor, A., Ethell, I. M., & Portera‐Cailliau, C. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00967-6 · Cited by 180 · see citing works
Self-citationThe Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00270 · Cited by 170 · see citing works
Self-citationEthridge, L. E., White, S. P., Mosconi, M. W., Wang, J., Pedapati, E. V., Erickson, C. A., Byerly, M., & Sweeney, J. A. (2017) · Molecular Autism · doi:10.1186/s13229-017-0140-1 · Cited by 166 · see citing works
Wen, T. H., Afroz, S., Reinhard, S. M., Palacios, A. R., Tapia, K., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhx258 · Cited by 165 · see citing works
Self-citationTranslation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.
Lovelace, J. W., Ethell, I. M., Binder, D. K., & Razak, K. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.012 · Cited by 154 · see citing works
Self-citationHe, C. X., Cantu, D. A., Mantri, S. S., Zeiger, W., Goel, A., & Portera‐Cailliau, C. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0651-17.2017 · Cited by 140 · see citing works
Sensory Processing Phenotypes in Fragile X Syndrome
Rais, M., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · ASN NEURO · doi:10.1177/1759091418801092 · Cited by 128 · see citing works
Self-citationMcDiarmid, T. A., Bernardos, A. C., & Rankin, C. H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.028 · Cited by 119 · see citing works
Of Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 118 · see citing works
Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance
Ethridge, L. E., Stefano, L. A. D., Schmitt, L., Woodruff, N., Brown, K. L., Tran, M., Wang, J., Pedapati, E. V., Erickson, C. A., & Sweeney, J. A. (2019) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2019.00060 · Cited by 114 · see citing works
Banerjee, A., Ifrim, M. F., Valdez‐Sinon, A. N., Raj, N., & Bassell, G. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.008 · Cited by 103 · see citing works
Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome
Jonak, C. R., Lovelace, J. W., Ethell, I. M., Razak, K. A., & Binder, D. K. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104794 · Cited by 87 · see citing works
Self-citationDevelopmental studies in fragile X syndrome
Razak, K., Dominick, K., & Erickson, C. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-09310-9 · Cited by 74 · see citing works
Self-citationSinclair, D., Featherstone, R. E., Naschek, M. J., Nam, A. J., Du, A., Wright, S., Pance, K., Melnychenko, O., Weger, R., Akuzawa, S., et al. (2017) · eNeuro · doi:10.1523/eneuro.0380-16.2017 · Cited by 84 · see citing works
Lovelace, J., Rais, M., Palacios, A. R., Shuai, X. S., Bishay, S., Popa, O., Pirbhoy, P. S., Binder, D., Nelson, D., Ethell, I. M., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz141 · Cited by 72 · see citing works
Self-citationDevelopmental changes in EEG phenotypes in a mouse model of Fragile X Syndrome
Wen, T. H., Lovelace, J., Ethell, I. M., Binder, D., & Razak, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.047 · Cited by 68 · see citing works
Self-citationBrain-wide visual habituation networks in wild type and fmr1 zebrafish
Legorreta, E. M., Constantin, L., Piber, M., Favre‐Bulle, I. A., Taylor, M. A., Blevins, A. S., Giacomotto, J., Bassett, D. S., Vanwalleghem, G. C., & Scott, E. K. (2022) · Nature Communications · doi:10.1038/s41467-022-28299-4 · Cited by 71 · see citing works
Translational use of event-related potentials to assess circuit integrity in ASD
Modi, M. E., & Şahin, M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.15 · Cited by 68 · see citing works
Disrupted circuits in mouse models of autism spectrum disorder and intellectual disability
Golden, C. E. M., Buxbaum, J. D., & Rubeis, S. D. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.11.006 · Cited by 67 · see citing works
Gonzalez, D., Tomasek, M. P., Hays, S. A., Sridhar, V., Ammanuel, S. G., Chang, C.-W., Pawlowski, K. S., Huber, K. M., & Gibson, J. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0886-19.2019 · Cited by 64 · see citing works
Mechanisms underlying auditory processing deficits in Fragile X syndrome
McCullagh, E., Rotschafer, S., Auerbach, B. D., Klug, A., Kaczmarek, L. K., Cramer, K. S., Kulesza, R., Razak, K. A., Lovelace, J., Lu, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902435r · Cited by 64 · see citing works
Self-citationFencková, M., Blok, L. E. R., Asztalos, L., Goodman, D. P., Čížek, P., Singgih, E. L., Glennon, J. C., IntHout, J., Zweier, C., Eichler, E. E., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.029 · Cited by 66 · see citing works
Pirbhoy, P. S., Rais, M., Lovelace, J. W., Woodard, W., Razak, K. A., Binder, D. K., & Ethell, I. M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15037 · Cited by 62 · see citing works
Self-citationWhat we can learn from a genetic rodent model about autism
Möhrle, D., Fernández, M. C., Peñagarikano, O., Frick, A., Allman, B. L., & Schmid, S. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.015 · Cited by 59 · see citing works
Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome
Goswami, S., Cavalier, S., Sridhar, V., Huber, K. M., & Gibson, J. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.002 · Cited by 55 · see citing works
Hyperexcitability and homeostasis in fragile X Syndrome.
Liu, X., Kumar, V., Tsai, N.-P., & Auerbach, B. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.805929 · Cited by 53 · see citing works
Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome
Razak, K., Binder, D., & Ethell, I. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.720752 · Cited by 47 · see citing works
Self-citationReusable Multielectrode Array Technique for Electroencephalography in Awake Freely Moving Mice
Jonak, C. R., Lovelace, J. W., Ethell, I. M., Razak, K. A., & Binder, D. K. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00053 · Cited by 42 · see citing works
Self-citationCarreño-Muñoz, M. I., Martins, F., Medrano, M., Aloisi, E., Pietropaolo, S., Dechaud, C., Subashi, E., Bony, G., Ginger, M. R., Moujahid, A., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.149 · Cited by 40 · see citing works
The Application of Adeno-Associated Viral Vector Gene Therapy to the Treatment of Fragile X Syndrome
Hampson, D. R., Hooper, A. W. M., & Niibori, Y. (2019) · Brain Sciences · doi:10.3390/brainsci9020032 · Cited by 36 · see citing works
Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome
Lovelace, J. W., Ethell, I. M., Binder, D. K., & Razak, K. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00771 · Cited by 36 · see citing works
Self-citationEEG as a translational biomarker and outcome measure in fragile X syndrome
Kenny, A., Wright, D., & Stanfield, A. C. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01796-2 · Cited by 33 · see citing works
Molecular Biomarkers in Fragile X Syndrome
Zafarullah, M., & Tassone, F. (2019) · Brain Sciences · doi:10.3390/brainsci9050096 · Cited by 36 · see citing works
Reinhard, S. M., Rais, M., Afroz, S., Hanania, Y., Pendi, K., Espinoza, K., Rosenthal, R., Binder, D. K., Ethell, I. M., & Razak, K. A. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107042 · Cited by 33 · see citing works
Self-citationCircuit-level theories for sensory dysfunction in autism: convergence across mouse models
Monday, H. R., Wang, H. C., & Feldman, D. E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1254297 · Cited by 31 · see citing works
Developmental Emergence of Phenotypes in the Auditory Brainstem Nuclei ofFmr1Knockout Mice
Rotschafer, S. E., & Cramer, K. S. (2017) · eNeuro · doi:10.1523/eneuro.0264-17.2017 · Cited by 30 · see citing works
Toledo, M. A., Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112068 · Cited by 31 · see citing works
Self-citationNguyen, A. O., Binder, D. K., Ethell, I. M., & Razak, K. A. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00706.2019 · Cited by 28 · see citing works
Self-citationKnoth, I. S., Lajnef, T., Rigoulot, S., Lacourse, K., Vannasing, P., Michaud, J. L., Jacquemont, S., Major, P., Jerbi, K., & Lippé, S. (2018) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-018-9223-3 · Cited by 31 · see citing works
Auditory Dysfunction in Animal Models of Autism Spectrum Disorder
Castro, A. C., & Monteiro, P. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.845155 · Cited by 34 · see citing works
Kulinich, A., Reinhard, S. M., Rais, M., Lovelace, J., Scott, V., Binder, D., Razak, K., & Ethell, I. M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104622 · Cited by 27 · see citing works
Self-citationKokash, J., Alderson, E. M., Reinhard, S. M., Crawford, C. A., Binder, D. K., Ethell, I. M., & Razak, K. A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.029 · Cited by 29 · see citing works
Self-citationMouse models of fragile X-related disorders
Willemsen, R., & Kooy, R. F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049485 · Cited by 27 · see citing works
Σεμελίδου, Ο., Acevedo, S. F., & Skoulakis, E. M. C. (2018) · eLife · doi:10.7554/elife.39569 · Cited by 29 · see citing works
Development of Neural Response to Novel Sounds in Fragile X Syndrome: Potential Biomarkers
Ethridge, L. E., Thaliath, A. P., Kraff, J., Nijhawan, K., & Berry‐Kravis, E. (2020) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-125.6.449 · Cited by 24 · see citing works
Rigoulot, S., Knoth, I. S., Lafontaine, M., Vannasing, P., Major, P., Jacquemont, S., Michaud, J. L., Jerbi, K., & Lippé, S. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.03.008 · Cited by 24 · see citing works
Detection of neurophysiological features in female R255X MeCP2 mutation mice
Dong, H., Erickson, K. R., Lee, J. R., Merritt, J. K., Fu, C., & Neul, J. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105083 · Cited by 22 · see citing works
Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome.
Rais, M., Lovelace, J., Shuai, X. S., Woodard, W., Bishay, S., Estrada, L., Sharma, A. R., Nguy, A., Kulinich, A., Pirbhoy, P. S., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105577 · Cited by 23 · see citing works
Self-citationJonak, C., Assad, S. A., Sandhu, M., Garcia, T. A., Rumschlag, J., Razak, K., & Binder, D. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106496 · Cited by 19 · see citing works
Self-citationGenetics, molecular control and clinical relevance of habituation learning
Blok, L. E. R., Boon, M., van Reijmersdal, B., Höffler, K. D., Fencková, M., & Schenck, A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104883 · Cited by 21 · see citing works
Altered frontal connectivity as a mechanism for executive function deficits in fragile X syndrome
Schmitt, L., Li, J., Liu, R., Horn, P. S., Sweeney, J. A., Erickson, C. A., & Pedapati, E. V. (2022) · Molecular Autism · doi:10.1186/s13229-022-00527-0 · Cited by 21 · see citing works
Rumschlag, J. A., & Razak, K. A. (2021) · Hearing Research · doi:10.1016/j.heares.2021.108380 · Cited by 19 · see citing works
Self-citationMechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome
Bülow, P., Segal, M., & Bassell, G. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116315 · Cited by 19 · see citing works
Auditory processing in rodent models of autism: a systematic review
Wilde, M., Constantin, L., Thorne, P. R., Montgomery, J. M., Scott, E. K., & Cheyne, J. E. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09458-6 · Cited by 18 · see citing works
Ren, B., Burkovetskaya, M., Jung, Y., Bergdolt, L., Totusek, S., Martinez‐Cerdeno, V., Stauch, K., Korade, Z., & Dunaevsky, A. (2023) · Glia · doi:10.1002/glia.24331 · Cited by 18 · see citing works
Developmental delays in cortical auditory temporal processing in a mouse model of Fragile X syndrome
Croom, K., Rumschlag, J., Erickson, M. A., Binder, D., & Razak, K. (2023) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-023-09496-8 · Cited by 14 · see citing works
Self-citationBisphenol A Exposure Induces Sensory Processing Deficits in Larval Zebrafish during Neurodevelopment
Scaramella, C., Alzagatiti, J. B., Creighton, C., Mankatala, S., Licea, F., Winter, G. M., Emtage, J., Wisnieski, J. R., Salazar, L., Hussain, A., et al. (2022) · eNeuro · doi:10.1523/eneuro.0020-22.2022 · Cited by 16 · see citing works
Holley, A. J., Shedd, A., Boggs, A. E., Lovelace, J. W., Erickson, C. A., Groß, C., Jankovic, M. J., Razak, K. A., Huber, K. M., & Gibson, J. R. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105767 · Cited by 16 · see citing works
Self-citationAdvances toward precision therapeutics for developmental and epileptic encephalopathies
Bertocchi, I., Cambiaghi, M., & Hasan, M. T. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1140679 · Cited by 14 · see citing works
Mascio, G., Bucci, D., Notartomaso, S., Liberatore, F., Antenucci, N., Scarselli, P., Imbriglio, T., Caruso, S., Gradini, R., Cannella, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01210-3 · Cited by 14 · see citing works
Liu, D.-C., Lee, K. Y., Lizarazo, S., Cook, J. K., & Tsai, N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105450 · Cited by 13 · see citing works
Dias, K.-R., Carlston, C. M., Blok, L. E. R., De Hayr, L., Nawaz, U., Evans, C.-A., Bayrak-Toydemir, P., Htun, S., Zhu, Y., Ma, A., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.06.001 · Cited by 13 · see citing works
Reliability of resting-state electrophysiology in fragile X syndrome
Liu, R., Pedapati, E. V., Schmitt, L., Shaffer, R. C., Smith, E. G., Dominick, K. C., DeStefano, L. A., Westerkamp, G. C., Horn, P. S., Sweeney, J. A., et al. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100070 · Cited by 11 · see citing works
Targeted therapy of cognitive deficits in fragile X syndrome
Puścian, A., Winiarski, M. J., Borowska, J., Łęski, S., Górkiewicz, T., Chaturvedi, M., Nowicka, K., Wołyniak, M., Chmielewska, J. J., Nikolaev, T., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01527-5 · Cited by 11 · see citing works
The electrophysiological markers of hyperacusis: a scoping review
Bigras, C., Villatte, B., Duda, V., & Hébert, S. (2022) · International Journal of Audiology · doi:10.1080/14992027.2022.2070083 · Cited by 11 · see citing works
FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability
Susco, S. G., Arias-García, M. A., López-Huerta, V. G., Beccard, A., Bara, A. M., Moffitt, J., Korn, J. A., Fu, Z., & Barrett, L. E. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.09.012 · Cited by 9 · see citing works
Cacciato‐Salcedo, S., Lao-Rodríguez, A. B., & Malmierca, M. S. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003309 · Cited by 8 · see citing works
Matrix Metalloproteinases in Invertebrates
Liu, X., Liu, D., Shen, Y., Huang, M., Gao, L., Zhang, Z., Liu, B., Zhao, B., & Pang, Q. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200429110945 · Cited by 7 · see citing works
From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research
van der Lei, M. B., & Kooy, R. F. (2025) · Biomedicines · doi:10.3390/biomedicines13040805 · Cited by 6 · see citing works
Hyper-extralemniscal model of Fragile X syndrome
Miyakoshi, M., Kim, H., Stefano, L. A. D., Schmitt, L., Norris, J. E., Ethridge, L. E., Erickson, C. A., & Pedapati, E. V. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf141 · Cited by 6 · see citing works
Brain-Wide Circuitry Underlying Altered Auditory Habituation in Zebrafish Models of Autism
Wilde, M., Ghanbari, A., Mancienne, T., Moran, A. L., Poulsen, R. E., Constantin, L., Lee, C. C. Y., Scholz, L. A., Arnold, J., Qin, W., et al. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.0364-26.2026 · Cited by 6 · see citing works
Tao, X., Croom, K., Newman‐Tancredi, A., Varney, M. A., & Razak, K. A. (2025) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09587-0 · Cited by 6 · see citing works
Self-citationLee, C. H., Kim, K. W., Lee, D.-H., Lee, S. M., & Kim, S. Y. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00642-3 · Cited by 6 · see citing works
Fencková, M., Asztalos, L., Čížek, P., Singgih, E. L., Blok, L. E. R., Glennon, J. C., IntHout, J., Zweier, C., Eichler, E. E., Bernier, R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/285981 · Cited by 6 · see citing works
Astrocytic GABA controls fidelity of temporal cortical processing in Fragile X Syndrome
Wagner, V. A., Thapa, R., Norman, A. O., Varallo, A., Wimberly, J., Rais, M., Gerasymchuk, D., Piepponen, P. T., Razak, K. A., Castrén, M. L., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107233 · Cited by 7 · see citing works
Self-citationRumschlag, J. A., Lovelace, J. W., Kokash, J., Hussain, A., & Razak, K. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.014 · Cited by 5 · see citing works
Self-citationKat, R., & Kas, M. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15808 · Cited by 5 · see citing works
Lu, C., & Linden, J. F. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03218-x · Cited by 3 · see citing works
Harkins, C. M., Dominick, K. C., Wink, L. K., Pedapati, E. V., Shaffer, R. C., Fitzpatrick, S. E., Davenport, M. H., Sweeney, J. A., & Erickson, C. A. (2017) · Pharmaceutical Medicine · doi:10.1007/s40290-017-0199-1 · Cited by 4 · see citing works
Auditory training in autism spectrum disorder: a case report
Ferreira, L., D’Agostini, A. R., Pichini, F. D. S., Pazini, E., Rechia, I. C., & Biaggio, E. P. V. (2019) · CoDAS · doi:10.1590/2317-1782/20192018212 · Cited by 4 · see citing works
Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Monaghan, D. T., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107355 · Cited by 3 · see citing works
Abdullah, A., Liu, X., Murari, K., Yan, J., & Cheng, N. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.062 · Cited by 4 · see citing works
Drug Discovery for Targeted Pharmacotherapy of Fragile X Syndrome
Scharf, S., Gasparini, F., Spooren, W., & Lindemann, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00018-4 · Cited by 1 · see citing works
Norman, A. O., Farooq, N., Sahni, A., Tapia, K., Breiner, D., Razak, K. A., & Ethell, I. M. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115184 · Cited by 2 · see citing works
Self-citationAltered auditory feature discrimination in a rat model of Fragile X Syndrome
Gauthier, D. W., James, N., & Auerbach, B. D. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003248 · Cited by 2 · see citing works
Shimono, K., Kashida, N., Nishigori, K., Iwasaki, T., Mizui, R., Yamamuro, K., Ishida, R., Toritsuka, M., Takeda, T., Tanakoshi, H., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03335-z · Cited by 2 · see citing works
Topography and Ensemble Activity in the Auditory Cortex of a Mouse Model of Fragile X Syndrome
Wadle, S. L., Ritter, T. C., Wadle, T. T. X., & Hirtz, J. J. (2024) · eNeuro · doi:10.1523/eneuro.0396-23.2024 · Cited by 1 · see citing works
Kokash, J., Rumschlag, J. A., & Razak, K. A. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.09.011 · Cited by 2 · see citing works
Self-citationHussain, A., & Razak, K. A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.05.026 · Cited by 2 · see citing works
Self-citationRais (2022) · doi:10.1101/2022.02.08.479618 · Cited by 2 · see citing works
Self-citationGoel, A., Razak, K. A., Chubykin, A. A., & Antoine, M. W. (2025) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-025-09634-4 · Cited by 1 · see citing works
Self-citationAuditory maturation and psychological risk in the first year of life
Rechia, I. C., Fattore, I. D. M., de Moraes, A. B., Biaggio, E. P. V., & de Souza, A. P. R. (2018) · CoDAS · doi:10.1590/2317-1782/20182017142 · Cited by 1 · see citing works
Legorreta, E. M. (2020) · The University of Queensland · doi:10.14264/uql.2020.647
Not Mismatch Negativity, but Modulation of Sensory N1 is Measured – Comment to Chen-Engerer et al.
Umbricht, D. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.12.015
Editorial: Neural markers of sensory processing in development
Ethridge, L. E., Auerbach, B. D., Contractor, A., Ethell, I. M., McCullagh, E. A., & Pedapati, E. V. (2023) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2023.1256437
Self-citationDysfunctional Circuit Mechanisms of Sensory Processing in FXS and ASD: Insights from Mouse Models
Goel, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-42383-3_1
Astrocytic contribution to auditory hypersensitivity in a mouse model of fragile X syndromePreprint
Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Padmashri, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638346
- Authors
- Lovelace, J. W., Wen, T. H., Reinhard, S., Hsu, M. S., Sidhu, H., Ethell, I. M., Binder, D. K., & Razak, K. A.
- Affiliations
- University of California, Riverside (US)
- Corresponding author
- Razak, Khaleel A.
- ORCID
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 89
- Pages
- 126-135
- ISSN
- 0969-9961 (ISSN-L)
- PMC
- PMC4785038
- OpenAlex
- W2279248612
- Semantic Scholar
- 146b38051e301c905588e3483b2588a6c0bf4103
- Cited by
- 115
- References
- 44
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 8 · 2023: 8 · 2022: 18 · 2021: 10 · 2020: 11 · 2019: 14 · 2018: 11 · 2017: 12 · 2016: 2
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 285 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neurobiology of Disease (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NICHD (U54HD082008)
- NSF
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- fragile X syndrome, Fmr1 knockout mice, MMP-9, auditory evoked potentials, habituation deficit, auditory hypersensitivity, auditory cortex, N1 amplitude, sensory processing deficits, autism spectrum disorder, FMRP, electrophysiological markers, intellectual disability, therapeutic target
- MeSH terms
- Acoustic Stimulation, Adaptation, Physiological, Animals, Auditory Cortex, Disease Models, Animal, Evoked Potentials, Auditory, Fragile X Syndrome, Up-Regulation, Mice, Knockout, Matrix Metalloproteinase 9, Mice, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review